Bone & Calcium
Director, San Francisco Coordinating Center
Sutter Health System
Professor of Medicine, Epidemiology and Biostatistics, emeritus
University of California, San Francisco
Gerard Karsenty is Paul A. Marks M.D., Professor, and Chair of the Department of Genetics and Development at Columbia University in New York City. His research focuses on all aspects of skeletal biology. Dr. Gerard Karsenty identified the master gene of bone formation and hypothesized that there must be a coordinated regulation of bone mass energy metabolism and reproduction. Exploring all aspects of this overarching hypothesis allowed him to reveal the existence of central control of bone mass and the endocrine nature of bone. Currently, his work focuses on identifying and deciphering all the functions of a bone hormone his laboratory discovered, osteocalcin.
Professor, osteoporosis and metabolic bone disease, at Aarhus University Hospital
Full Professor of Clinical Chemistry,
Coordinator of Biochemistry career,
Codirector of Mineral Metabolism and Osteopathy Research Laboratory,
National University of La Plata, Argentina.
Director of Clinical Biochemistry Laboratory,
“Horacio Cestino” General Hospital,
Buenos Aires province Ministry of Health, Argentina.
Assoc. Professor, Dr Camilla Schalin-Jäntti from Finland, is the immediate past chair of the ESE Education Committee
CV – Adrenal
Richard J. Auchus, MD, PhD, FACE. The James A. Shayman and Andrea S. Kevrick Professor of Translational Medicine. Professor of Pharmacology and Internal Medicine, Division of Metabolism, Endocrinology, & Diabetes. University of Michigan
Professor of Medicine, Division of Medical Oncology, University of Texas Health Science Center at San Antonio, Texas, USA
Professor of University of Sao Paulo
Chief of Adrenal Unit
Hospital das Clinicas da Faculdade de Medicina USP
Instituto do Cancer do Estado de Sao Paulo
Gary D. Hammer, M.D., Ph.D. is a Professor in the Departments of Internal Medicine (Metabolism, Endocrinology & Diabetes), Cell & Developmental Biology, and Molecular & Integrative Physiology at the University of Michigan (UofM). Before arriving in Michigan in 1999, he obtained his M.D. and Ph.D. in Neuroscience from Tufts University and completed his residency in Internal Medicine followed by a clinical fellowship in Endocrinology and a post-doctoral fellowship with Holly Ingraham at the University of California – San Francisco. He currently serves as the Director of the Endocrine Oncology Program in the Comprehensive Cancer Center at UofM where he holds the Millie Schembechler Professorship in Adrenal Cancer. He is immediate past Director of the UofM Center for Organogenesis. He has brokered the recent renaissance of the current Michigan team of adrenal scientists that includes a who’s who in the clinical and basic
study of adrenal disease. He received the UofM Jerome Conn Award for Outstanding Research in Internal Medicine, the Endocrine Society Edwin B. Astwood Award for Outstanding Research in Endocrinology and is a member of the American Society for Clinical Investigation and Association of American Physicians. He is the editor of three textbooks: Adrenocortical Carcinoma: Basic Science and Clinical Concepts (Springer 2011), Pathophysiology of Disease: An Introduction to Clinical Medicine (Harper Row, 2014; 2018) and Genetics Steroid Disorders (Elsevier, 2014). In addition to being a founding organizer of the biennial International Adrenal Cancer Symposium, he also is a member of the coordinating team of the biennial International Adrenal Meetings and has served in numerous capacities across the tripartite constituencies of the Endocrine Society
including Chair of the Student Affairs Committee, Chair of the Mentoring Task Force, Basic Science Chair of the Annual Meeting Trainee Day, Council Member at Large and Society Ambassador to King Edward Memorial Hospital in Mumbai India as part of the inaugural Endocrine Society Ambassador Exchange Program. Most recently he has served as the
Clinical Research Chair of the 2016 Endocrine Society Annual Meeting, the Overall Chair of the 2017 Annual Meeting, and current President of the Society. Research projects in his own laboratory are aimed at elucidating the mechanisms by which growth factor signaling and transcriptional programs initiate adrenal-specific growth and differentiation with an emphasis on dysregulated adrenocortical stem cells in development and cancer. He is a co-founder of the companies Millendo and Vasaragen that focus on therapies for adrenal diseases and related disorders. Collaborative work with colleagues has led to the development of new national and international therapeutic trials with biological-based therapies for adrenal cancer that target the molecular defects in cancer while sparing normal tissue.
Professor of Endocrine Cancer and Hormonal Disorders
Department of Endocrine Neoplasia
The university of Texas MD Anderson Cancer Center
Jerome W. Conn Professor
Departments of Molecular & Integrative Physiology and Internal Medicine
University of Michigan
Ann Arbor, Michigan
Director, Centro de Investigaciones Endocrinológicas, Hospital de Niños Ricardo Gutiérrez, Buenos Aires
Professor of Endocrinology
Dr. Vaidya is the Director of the Center for Adrenal Disorders at Brigham and Women’s Hospital and Associate Professor at Harvard Medical School. He oversees the multi-disciplinary clinical care of patients with adrenal diseases and runs a translational adrenal research program.
Brian Walker is Chair of Medicine and Pro Vice Chancellor for Research Strategy & Resources at Newcastle University, UK. Until 2017, he was Professor of Endocrinology and Head of the BHF Centre for Cardiovascular Science at the University of Edinburgh, UK. A clinical Endocrinologist, his research over >25 years – spanning rodent models, experimental medicine, drug discovery, and genetic epidemiology – has systematically documented the contributions of glucocorticoids to cardiovascular disease risk, identified novel determinants of tissue glucocorticoid action, and targeted these with new drugs.
Diabetes, Obesity and Dyslipidemia
Pablo Aschner MD, MSc
Specialist in Internal Medicine and Endocrinology with master degree in Clinical Epidemiology
Professor of Endocrinology at the Javeriana University and Senior Research Advisor at the San Ignacio University Hospital
Scientific Director of the Colombian Diabetes Association
Director of Medicine Department at Catholic University of Rio de Janeiro
Past-President of World Obesity Federation
Head of DIAMET lab at Pere Virgili Health Institute-CIBERDEM and assistant professor at Rovira Virgili University (Tarragona, Spain).
More information about my research lines at www.diamet.org
Karolinska Insitutet, Stockholm
Dr. Ingrid Libman received her medical degree from the Universidad Nacional de Rosario, Argentina and her PhD from the University of Pittsburgh. She completed her clinical training at UPMC Children’s Hospital of Pittsburgh. She is currently Associate Professor of Pediatric Endocrinology and Diabetes and Director of the Diabetes Program at Children’s Hospital of Pittsburgh.
Profesor consulto del Instituto Universitario del Hospital Italiano de Buenos Aires (IUHI)
Ex Jefe y actual Miembro de la Sección Diabetes y Metabolismo del Servicio de Endocrinologi´a y Medicina Nuclear. Hospital Italiano de Buenos Aires
Presidente de la Sociedad Argentina de Diabetes (2010-2012)
Director de los Talleres de Tratamiento Intensificado en Diabetes (IUHI)
Co-director de la Maestría en Metabolismo y Atero-trombosis (IUHI)
Dr Gloria López Full Professor of Medicine Faculty of Medicine, Universidad de Chile
Director Diabetes Specialization Program, Postgraduate Scchol, Hospital Clínico Universida de Chile
Dr. V Mohan
Chairman and Chief Diabetologist
Dr Mohan’s Diabetes Specialities Centre
Professor Peter Rossing head of diabetes complications research at Steno Diabetes Center COpenhagen and professor endocrinology University of Copenhagen
Professor of internal medicine
Desmond Schatz, MD is Professor and Interim Chairman of Pediatrics, Medical Director of the Diabetes Institute and Director of the Clinical Research Center within the CTSI at the University of Florida, Gainesville. He served as President of Science and Medicine of the American Diabetes Association in 2016. Dr. Schatz has been involved in Type 1 diabetes research since the mid 1980’s and has published over 360 manuscripts, the majority related to the prediction, natural history, genetics, immunopathogenesis and prevention of the disease, as well as the management of children and adolescents with Type 1 diabetes. He is the Principal Investigator (PI) on several NIH awards. He is the PI of the University of Florida Clinical Center participating in the NIH-funded TrialNet (a founding member of the DPT-1 in 1994). He is co-PI on a Program Project Grant seeking to understand the immunopathogenesis of Type 1 diabetes, and also serve as PI for the NIH-funded international newborn genetic screening (TEDDY) program in North Central Florida. He is the PI on the NIH-funded Human Islet Research Network (HIRN) Grant evaluating novel markers and mechanisms of beta cell destruction. He is the PI of the University of Florida site participating in the Type 1 Diabetes Exchange. Dr. Schatz has served in numerous capacities (Committees, Study Sections) for the American Diabetes Association, JDRF and NIH. He serves on the external advisory board for the NIH- and CDC-funded SEARCH and TODAY studies in youth with Type 2 diabetes and on the JDRF-funded Australian INIT II studies. He was awarded the Mary Tyler Moore and S Robert Levine JDRF Excellence in Clinical Research Award, the 2009 Cure Award from the American Diabetes Association, the 2010 Public Policy Leadership Award, the prestigious Banting Medal for service from the American Diabetes Association and the ISPAD Prize for achievement (the highest honor of the International Society for Pediatric and Adolescent Diabetes)
Advisor Diabetes Unit Instituto Cardiovascular de Buenos Aires
He was president of the Argentiane Society of Diabetes, of the Argentine Society of Endocrinology and Metabolism and of the Argentine Federation of Endocrinology Societes
Professor Jaakko Tuomilehto qualified as MD in 1973 and MA (sociology) in 1975 and PhD in Public Health in 1975. He is Professor Emeritus of Public Health of University of Helsinki, Finland, and Visiting Professor at National Institute for Health and Welfare in Helsinki, Finland, King Abdulaziz University in Jeddah, Saudi Arabia, and National School of Public Health, Madrid, Spain.
His research interests include the epidemiology and prevention of non-communicable diseases such as diabetes, cardiovascular disease, cancer and dementia. He has coordinated numerous scientific research projects and contributed many landmark studies.
He has been actively involved in several committees, and advisory boards nationally and internationally and has been chairing multiple scientific organisations. Currently he serves as the Editor-in-Chief of Primary Care Diabetes journal and Editorial Board member in many other scientific journals.
He has contributed to over 1800 scientific peer-reviewed publications and is among the most cited authors in the field of diabetes worldwide with >157,000 citations. His h-index is 176.
Female Reproduction – Fertility
Professor Anuja Dokras
Director, Penn PCOS Center
University of Pennsylvania, Philadelphia, USA
Full Professor of Sao Paulo Medical School
Dr. Shaw is a pediatric endocrinologist and a tenure-track clinical investigator at the National Institute of Environmental Health Sciences (NIEHS) in North Carolina, USA. She studies disorders of puberty using clinical and translational research models.
Dr. Corrine Welt
Professor of Medicine
Chief of Endocrinology, Metabolism and Diabetes
University of Utah
Professor and Chief of Pediatric Endocrinology
Institute of Maternal and Child Research
University of Chile
Dr. Horacio Domené has been coordinator of the molecular Biology of the Centro de Investigaciones Endocrinológicas (CEDIE – CONICET).
Dra Cecilia calvar
Chief of the Endocrine Unit at Fernández Hospital
Leder of the Endocrine Unit Team of comprehensive health care for Transgender people
President Italian Society of Andrology and Sexual Medicice, co-chair Guidelines Commitee European Acedemy of Andrology, Chiar Scientific Committee European Society for sexual Medicine
Endocrinology Unit, Medical Department, Azienda Usl Bologna Maggiore-Bellaria Hospital, Bologna, Italy,
Stephen M. Rosenthal, M.D.
Professor of Pediatrics
Division of Pediatric Endocrinology
Medical Director, Child and Adolescent Gender Center
University of California, San Francisco
San Francisco, California USA
Director, Endocrine Society
Past President, Pediatric Endocrine Society
Dr Russell is an Endocrinologist and General Physician at Austin Health in Melbourne, Australia, and a clinical trial researcher in Professor Mathis Grossmann’s clinical andrology research group at the University of Melbourne. His research has focussed on the biological role of estradiol in men.
Plenary Professor of Molecular Biology, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires.
Superior Investigator of CONICET.
Full Professor. Head of the Louvain Drug Research Institute at the Université catholique de Louvain (Uclouvain, Belgium). Pionner in the Discovery of how prebiotic nutrients target the gut microbiota to improve health.
Oncology NE Tumors
Chief of the Gastrointestinal Tumor Division, Instituto Alexander Fleming
Neuroendocrine Tumor Unit, Hospital de Gastroenterologìa Bonorino Udaondo, Buenos Aires Argentina
Member of ENETS and member of Advisory Board ENETS 2008 – 2018
Founder member of ARGENTUM GROUP, (argentinian group of NETs tumours) 2005
Pituitary – Neuroendocrinology
Member of the Research Scientific Career of the National Research Council – CONICET- of Argentina, Professor at the University of Buenos Aires, External Scientific Member of the Max Planck Society and Funding and actual Director of the BioMedicine Institute of Buenos Aires- CONICET- Partner Institute Max Planck Society.
I am an endocrinologist and a clinical researcher (MD PhD), currently working in a Pituitary Disease Study Group led by Professor Susan Webb in Barcelona. My research is focused on neuroendocrinology, in particular, pituitary diseases and pathophysiology of the neurohormone oxytocin.
Professor of Endocrinology – Medical School – Universidade Federal do Rio de Janeiro
Professor of Nephrology
Director, Interdisciplinary Oxytocin Research Program
Neuroendocrine Unit, Massachusetts General Hospital
Associate Professor of Medicine, Harvard Medical School
Boston, MA USA
Raul M. Luque is Associate Professor of Cell Biology at the Department of Cell Biology of the University of Córdoba (UCO), and Head of the -OncObesity and Metabolism- group at the Maimonides Biomedical Research Institute of Córdoba, Spain. He has published over 150 articles in international peer-reviewed journals, including a significant number of research papers and invited reviews in authoritative, highly-ranked journals. He has participated as invited speaker in numerous international meetings, and has served as member of the Editorial Board of prestigious journals of the field (JCEM, Neuroendocrinology, JOE/JME, among others). He is an active promoter of the Spanish (SEEN) and European (ESE and ENEA) Societies of Endocrinology, Metabolism and Nutrition (e.g., in the last 5 years he has been Member of the Executive Committee of the SEEN and ENEA).
Professor of Medicine and Physiology
Chief, Endocrinology and Metabolism
Washington, DC USA
Scientific researcher of the National Research Council of Argentina-(CONICET).
HEAD of Laboratory of Hormonal Physiology and pathology. Instituto de Biología y Medicina Experimental- CONICET
Her laboratory studies the physiology and pathology of the pituitary gland. Specifically, they are looking for alternative therapies to treat prolactinomas that are resistant to the current therapy with dopaminergic drugs.
Deputy Director of the Cordeliers Research Center in Paris. Head of the Physiology, Metabolism Department
Professor Alfredo Ulloa-Aguirre,
Research Support Network (RAI)
National University of Mexico UNAM)-National Institutes of Health
Takashi Akamizu is Professor and Chairman of Medicine/Endocrinlogy/Diabetes/Metabolism at Wakayama Medical University. He is currently the President of Japan Endocrine Society, the President of AOTA and an Associate Editor of JCEM. His major research interests include thyroid disease, ghrelin and IgG4-related endocrine disease.
Thyroid Workgroup Coordinator, Endocrinology Division, Carlos G. Durand Hospital, Buenos Aires, Argentina.
Professor of Endocrinology & Director Clinician PhD Programme & Clinical Research Facility, University of Cambridge
Consultant Paediatric Endocrinologist and University Reader
April 3, 1985: M.D. degree (cum laude), Pisa University, Italy
July 9, 1988 Speciality degree in Endocrinology: (cum laude), Pisa University, Italy
Present position: Associate Professor of Endocrinology, Dept of Endocrinology, Pisa University, Italy.
RESEARCH EXPERIENCE IN FOREIGN INSTITUTIONS:
1989-1990: Postdoctoral Research Fellow at the Université Libre de Bruxelles, Belgium.
1994-1997: Postdoctoral Assistant, Division of Endocrinology, Cedars-Sinai Medical Center/UCLA School of Medicine, Los Angeles, CA, (6 months) and then Division of Endocrinology and Metabolism, University of Cincinnati, College of Medicine, Cincinnati, OH, USA (24 months).
2011 The European Thyroid Association Max Pierre-Konig poster award in recognition of the best poster in clinical thyroidology.
2012 “Light of Life Foundation” international award dedicated to the best thyroid cancer researcher of the year, Sloan Kettering Memorial Cancer Center, New York.
International awards for “excellence in published clinical research” in the J Clin Endocrinol Metab in the years 2006, 2012, 2015 and 2016.
2018 European Thyroid Association (ETA) award as a distinguished scientist and in recognition of her outstanding contribution to Thyroid Research.
More than 200 papers in peer-reviewed journals, more than 60 manuscripts in meetings’ proceedings and book chapters and more than 300 Abstracts for National/ International Meetings.
Principal Investigator in 20 phase II or III clinical trials on drugs for medullary and dedifferentiated thyroid cancer treatment.
Head and Neck Surgical Oncologist
Director Biomedical Research Consortium – Chile
Professor of Surgery Pontificia Universdad Católica de Chile
Principal Researcher from the Argentinian National Research Council (CONICET)
Associate Professor at the Faculty of Chemical Sciences of the National University of Cordoba, Argentina
Leader of a research lab interested in the study of thyroid hormone functionality in normal and pathological conditions.
Head Thyroid Section – Hospital de Clinicas – University of Buenos Aires
President Elect Latin American Thyroid Society
Terry Smith – University of Michigan, Ann Arbor, MI, USA